公司資料
Phio Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- PHIO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.02 USD (+2.09%)
收盤價
最後更新: 2026年9月17日
13M USD
市值
股價為何變動
截至 2026年9月17日，PHIO 上漲 2.09%，收於 $1.02。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Phio Pharmaceuticals is a biotechnology company focused on immune-oncology and RNA interference-based approaches to cancer. Its story centers on using gene-silencing science to improve tumor treatment.
所在地與產業分類
Phio is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商業模式特徵
The company depends on preclinical and early clinical validation, capital discipline, and the ability to show that its platform can create a meaningful cancer signal. Investors usually watch translational progress and financing runway.
生技產業定位
Phio occupies a speculative RNAi-oncology niche within biotech. The stock is catalyst-sensitive because the company is still proving whether its platform can matter clinically.
未來催化劑
- Phio’s catalysts are its immune-oncology platform and any clinical or partnership update that shows the technology can still produce value. The company remains early and data-dependent.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。